Impact of In Vitro Passive Permeability in a P-gp-transfected LLC-PK1 Model on the Prediction of the Rat and Human Unbound Brain-to-Plasma Concentration Ratio-Reference-Cited by-同舟云学术

Impact of In Vitro Passive Permeability in a P-gp-transfected LLC-PK1 Model on the Prediction of the Rat and Human Unbound Brain-to-Plasma Concentration Ratio

Published:2020-08-27 Issue:9 Volume:37 Page:
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Nicolaï Johan^ORCID,Chapy Hélène,Gillent Eric,Saunders Kenneth,Ungell Anna-Lena,Nicolas Jean-Marie,Chanteux Hugues

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s11095-020-02867-z.pdf

Reference70 articles.

1. Johnson IP. Age-related neurodegenerative disease research needs aging models. Front Aging Neurosci. 2015;7:168.

2. Gribkoff VK, Kaczmarek LK. The need for new approaches in CNS drug discovery: why drugs have failed, and what can be done to improve outcomes. Neuropharmacology. 2017;120:11–9.

3. Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32(11):1959–72.

4. Hammarlund-Udenaes M, Lange ECMd, Thorne RG, American Association of Pharmaceutical Scientists. Drug delivery to the brain : physiological concepts, methodologies, and approaches. New York: AAPS Press : Springer; 2014. xx, 731 pages p.

5. Nicholls G, Youdim K, Royal Society of Chemistry (Great Britain). Drug transporters. Cambridge: Royal Society Of Chemistry; 2016. 2 volumes p.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reliability of in vitro data for the mechanistic prediction of brain extracellular fluid pharmacokinetics of P-glycoprotein substrates in vivo; are we scaling correctly?;2024-08-14

2. Treating Alzheimer’s disease using nanoparticle-mediated drug delivery strategies/systems;Ageing Research Reviews;2024-06

3. Application of a new MDCKII-MDR1 cell model to measure the extent of drug distribution in vitro at equilibrium for prediction of in vivo unbound brain-to-plasma drug distribution;Fluids and Barriers of the CNS;2024-01-25

4. Application of a new MDCKII-MDR1 cell model to measure the extent of drug distribution in vitro at equilibrium for prediction of in vivo unbound brain-to-plasma drug distribution.;2023-09-01

5. Recent advances in the in vitro and in vivo methods to assess impact of P‐glycoprotein and breast cancer resistance protein transporters in central nervous system drug disposition;Biopharmaceutics & Drug Disposition;2023-02